Can a Belgian lab breakthrough reshape how liver cancer is treated?

Belgian researchers, according to Francophone outlets including RTBF, La Libre, DH and 7sur7, have identified a new therapeutic avenue against liver cancer. Liver cancer — most commonly hepatocellular carcinoma — is often linked to chronic liver disease (hepatitis, alcohol, fatty liver disease) and is typically diagnosed late with limited treatment options. The reported finding appears to be early-stage laboratory science identifying a targetable biological mechanism, not an approved treatment. Belgium is a significant European centre for oncology research through its university hospitals (Leuven, Ghent, Liège, Brussels) and life-sciences sector.